Hossein Borghaei, DO, MS: I’m going to come back to our physicians. Ms. Ferris, I’m going to need your input in the next section also. I want to start talking about all the barriers we’re facing and ...
Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...
SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...
Two medical oncologists break down the role molecular testing has when treating NSCLC, from guidelines to common methods to barriers. Joshua Sabari, MD: I recommend testing up front. All patients with ...
COVID-19 tests are in greater demand than ever, and new data about the Omicron variant can make picking and using different types of tests confusing. Molecular tests for COVID-19, like the "RT-PCR" ...
Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...
Camryn was diagnosed with a low-grade glioma at age two after her parents noticed a lazy eye. Sixteen years, 11 brain surgeries and over six years of chemotherapy treatment, Camryn is now ...
Antimicrobial resistance (AMR) remains a major global healthcare challenge, undermining the effectiveness of treatments for common infections and threatening modern medical advances. Improved ...
Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...
Alexander Spira, MD, PhD, FACP provides an overview of molecular testing in NSCLC. Alexander Spira, MD, PhD, FACP: Guidelines and recommendations around molecular testing in advanced non-small cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results